8 results found.

Lung Cancer, Squamous Lung Dysplasia, or Tobacco Use Disorder Clinical Trial using deuterated phenanthrene tetraol; pharmacological study; laboratory biomarker analysis

Masonic Cancer Center, University of Minnesota - Recruiting 18 years or older.
- Correlation of [D10] Phenanthrene Metabolism With Bronchoepitheial Dysplasia and Metaplasia in Smokers at High Risk for Lung Cancer.
deuterated phenanthrene tetraol; pharmacological study; laboratory biomarker analysis

Tobacco Use Disorder Clinical Trial using smoking cessation intervention; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis; ecigarettes

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Exploring Current Smokers' Interest in Using Smokeless Tobacco Products Smokeless Tobacco Substitution for Cigarettes.
smoking cessation intervention; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis; ecigarettes

Tobacco Use Disorder Clinical Trial using electronic cigarette; nicotine inhaler

New York State Psychiatric Institute - Recruiting 18 years to 60 years.
- Electronic Nicotine Delivery Devices (ENDDs) or Nicotine Inhaler for Smoking Cessation.
electronic cigarette; nicotine inhaler

Schizophrenia, Substance Abuse, Cocaine Abuse, or Tobacco Use Dis Clinical Trial using Various Screening psychiatric and medical assessments

University of Maryland - Recruiting 18 years to 64 years.
- Screening Protocol for the Evaluation of Research Participants.
Various Screening psychiatric and medical assessments

Tobacco Use Disorder, or Smoking Clinical Trial using Aspirin 325 mg daily; Celecoxib 200 mg BID

Vanderbilt University - Recruiting 35 years to 90 years.
- Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers.
Aspirin 325 mg daily; Celecoxib 200 mg BID

Cigarette Smoking, Nicotine Dependence, Post-traumatic Stress Dis Clinical Trial using Varenicline; Medication Management Counseling; Prolonged Exposure

University of Pennsylvania - Recruiting 18 years to 75 years.
- Treatment of Smoking Among Individuals With PTSD: A Phase II, Randomized Study of Varenicline and Cognitive Behavioral Therapy.
Varenicline; Medication Management Counseling; Prolonged Exposure

Tobacco Use Disorder Clinical Trial using Bupropion; Bupropion + Naltrexone

National Institute on Drug Abuse (NIDA) - Recruiting 18 years or older.
- Phase II Randomized, Double-Blind Trial of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation.
Bupropion; Bupropion + Naltrexone

Tobacco Use Disorder Clinical Trial using Pediatric residency training on tobacco

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting N/A or older.
- Pediatric Residency Training on Tobacco.
Pediatric residency training on tobacco